Flavia Pagano

Dr. Flavia Pagano

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Journal of Minimally Invasive Gynecology
Verified
Journal Article
Open access
Flavia PaganoFlavia Pagano
Flavia Pagano
ASAdriana Schwander
Adriana Schwander
CVCloé Vaineau
Cloé Vaineau
LKLaura Knabben
Laura Knabben
KNKonstantinos Nirgianakis
Konstantinos Nirgianakis
MMMichael Mueller
Michael Mueller
To identify characteristics indicating preoperatively the presence of diaphragmatic endometriosis (DE). Comparison of characteristics of patients with diaphragmatic endometriosis (DE) with characteristics of patients with abdominal endometriosis without diaphragmatic involvement, in a prospective cohort study. Tertiary referral center; endometriosis center. A total of 1372 patients with histologically proven endometriosis. Surgery performed laparoscopically under general anesthesia. All patients with suspected endometriosis underwent a complete bilateral inspection of the diaphragm. Demographic and clinical pathologic characteristics were evaluated using basic descriptive statistics (comparison of the groups using the χ2 test and the Mann-Whitney t test). A logistic regression analysis was performed to evaluate the relationship (hazard ratio) between symptoms and the presence of DE. DE was diagnosed in 4.7% of the patients (65 of 1372). There was no significant difference between the 2 groups (patients with abdominal endometriosis with or without DE) with regard to typical endometriosis pain (dysmenorrhea, dyschezia, dysuria, and/or dyspareunia). However, in the DE group, diaphragmatic pain was present significantly more often preoperatively (27.7% vs 1.8%, p <.001). Four DE patients (6.1 %) were asymptomatic (with infertility the indication for surgery). In the DE group, 78.4 % had advanced stages of endometriosis (revised American Fertility Society III° or IV°); the left lower pelvis was affected in more patients (73.8%). In cases of ovarian endometriosis, patients with DE showed a significantly higher prevalence of left ovaries involvement (left 63% vs right 35.7%, p <.001). Patients with DE had a significantly higher rate of infertility (49.2% vs 28.7%, p <.05). Patients with shoulder pain, infertility, and/or endometriosis in the left pelvis have a significant higher risk of DE and therefore need specific preoperative counseling and if indicated surgical treatment.

1 December 2024 in Journal of Adolescent and Young Adult Oncology
Verified
Journal Article
Open access
MSMarcel Steinmann
Marcel Steinmann
ARAnita Rietschin
Anita Rietschin
Flavia PaganoFlavia Pagano
Flavia Pagano
TKTanya Karrer
Tanya Karrer
AKAttila Kollár
Attila Kollár
MWMichael Von Wolff
Michael Von Wolff
Increasing awareness of gonadotoxicity in cancer treatments and infertility risk is essential for counseling young cancer patients. While fertility preservation options are available in many countries, limited data on gonadotoxicity hinder recommendations, especially for soft tissue cancers. This review, part of the FertiTOX project ( www.fertitox.com ), organized by FertiPROTEKT ( www.fertiprotekt.com ), aims to address this knowledge gap to improve fertility preservation guidance. We performed a systematic literature search on gonadotoxicity in soft tissue sarcoma (STS) cancer treatments. Only patients without metastases or recurrent disease were considered. “Suspected infertility” was defined based on low ovarian reserve parameters, low inhibin B levels, high gonadotropin concentration, gonadal dysfunction, amenorrhea, oligomenorrhea, azoospermia, or oligozoospermia due to limited infertility data. The study quality was assessed using the Newcastle–Ottawa Scale. The search yielded 3309 abstracts, with 138 undergoing full-text analysis. Eight studies on STS were included. Suspected infertility was observed in 20 of 28 females (71.4%, range 0–100%) and 38 of 63 males (60.3%, range 34.8–100%) with STS. Six of the eight studies received high-quality scores on the NOS, while two received a fair score. Our data suggest a high risk of infertility from chemotherapy in pre- and postpubertal STS survivors. This underscores the importance of considering fertility preservation measures when counseling these patients.

6 April 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Flavia PaganoFlavia Pagano
Flavia Pagano
FSFlurina Annacarina Maria Saner
Flurina Annacarina Maria Saner
CICodruta Ionescu
Codruta Ionescu
ERElena Riggenbach
Elena Riggenbach
KLKristina Lössl
Kristina Lössl
SISara Imboden
Sara Imboden
Background: Intraoperative radiation therapy (IORT) is the delivery of a single large dose of radiation to a limited volume of tissue at the time of surgery. The aim of this study is to assess outcomes in patients who underwent IORT for gynecologic malignancies and to identify parameters that can predict a good outcome. Methods: This is a retrospective single-center cohort study including all women treated with surgery and IORT for a primary or recurrent gynecologic cancer between 2014 and 2022 at the Bern University Hospital, Switzerland. Results: A total of 30 patients with gynecologic malignancies were treated with surgery and IORT. Of these patients, 63.3% presented with cervical cancer, 23.3% with sarcoma, 10% with endometrial cancer, and 3.3% with carcinosarcoma of the ovary. Seventy percent (21/30) of women had an ECOG performance status of 0 at time of IORT. There was no difference in survival among women with incomplete surgical resection (R1/2 vs. R0) at time of IORT. Fifty percent of patients suffered postoperative complication of Clavien-Dindo grade >III, but there was no significant correlation of these complications to overall survival (p = 0.58). Three-year disease-free survival was 53.3%, and five-year overall survival was 53.3%. ECOG status was a significant parameter in DSS (p = 0.002) and OS (p = 0.02). Conclusion: Surgery with IORT is potentially a good treatment option in selected patients with recurrent or locally advanced cervical or endometrial cancer. An ECOG status of 0 is a significant parameter for good outcomes and should be taken into consideration for treatment decisions.

6 September 2024 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
Flavia PaganoFlavia Pagano
Flavia Pagano
IDIoannis Dedes
Ioannis Dedes
SISara Imboden
Sara Imboden
MMMichael D. Mueller
Michael D. Mueller

30 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Flavia PaganoFlavia Pagano
Flavia Pagano
IDIoannis Dedes
Ioannis Dedes
CVCloé Vaineau
Cloé Vaineau
FSFranziska Siegenthaler
Franziska Siegenthaler
SISara Imboden
Sara Imboden
MMMichael Mueller
Michael Mueller
Background: Endometrioma recurrence after laparoscopic cystectomy remains a clinical challenge in the long-term management of endometriosis. The Empressin Injection Technique (EIT), which involves the use of a vasopressin analog during surgery, may reduce recurrence by improving the completeness of cyst removal. This study aimed to evaluate the impact of the EIT on recurrence rates compared to standard cystectomy without Empressin. Methods: We conducted a retrospective case–control study of 263 patients who underwent laparoscopic cystectomy for unilateral or bilateral endometriomas between 2014 and 2024 at a tertiary endometriosis referral center. The patients were divided into two groups: EIT (n = 110) and control (n = 153). In the EIT group, 10 mL of diluted Empressin (1 mL in 100 mL NaCl 0.9%) was injected at the cyst capsule–ovarian cortex interface prior to stripping. Demographic and clinical variables were analyzed using descriptive statistics (chi-square test and the Mann–Whitney t-test) and logistic regression to identify factors associated with recurrence between the two groups. Results: No significant differences were found between the groups regarding age, BMI, #ENZIAN O score, or r-ASRM stage. No intraoperative or postoperative complications were reported. Recurrence was significantly lower in the EIT group (5.5%) compared to the control group (19.6%) (p = 0.001; OR 0.2, 95% CI: 0.08–0.55). Hormonal therapy was administered postoperatively in 69.1% of EIT patients and 62.5% of controls. Pregnancy rates were comparable between the groups. Repeat surgery for recurrence was required only in the control group (4.2%, p = 0.004). Conclusions: Use of Empressin during laparoscopic cystectomy significantly reduces endometrioma recurrence without adverse effects, particularly when combined with postoperative hormonal therapy.

2 November 2026 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
Flavia PaganoFlavia Pagano
Flavia Pagano
PSPál Botond Sík
Pál Botond Sík
SISara Imboden
Sara Imboden
ABAttila Bokor
Attila Bokor
MMMichael D. Mueller
Michael D. Mueller
Objective: To evaluate perioperative morbidity, factors associated with postoperative complications and documented recurrence after one‐stage laparoscopic resection for multicompartment deep endometriosis. Design: Retrospective multicentre cohort study. Setting: Two tertiary referral centres specialised in endometriosis surgery (Bern, Switzerland; Budapest, Hungary). Population: A total of 299 consecutive patients with pathologically confirmed deep endometriosis undergoing one‐stage laparoscopic resection between January 2017 and December 2025. Interventions: One‐stage laparoscopic resection of multicompartment deep endometriosis. Measurements and Main Results: Clinically relevant postoperative complications were defined as Clavien–Dindo Grade ≥ II. Multivariable logistic regression assessed associated factors. Recurrence‐free survival was evaluated using Kaplan–Meier analysis in patients with an available recurrence time or censoring time. Postoperative complications occurred in 36/299 patients (12.0%), including 35/299 (11.7%) with Grade ≥ II complications and 14/299 (4.7%) with Grade ≥ IIIb complications. Greater #ENZIAN deep endometriosis anatomical extent was independently associated with clinically relevant complications (adjusted odds ratio 1.51 per additional involved compartment, 95% confidence interval 1.04–2.18). Documented recurrence occurred in 43/299 patients (14.4%) and 26/299 (8.7%) underwent reoperation for recurrence. Follow‐up duration was available for 231/299 patients (77.3%). Recurrence‐free survival did not differ significantly according to bowel (log‐rank p = 0.431) or bladder surgical technique ( p = 0.116). Conclusion: Greater #ENZIAN deep endometriosis anatomical extent was independently associated with clinically relevant postoperative complications following one‐stage surgery for multicompartment deep endometriosis, suggesting that overall anatomical disease extent may better reflect surgical complexity than involvement of a single anatomical site. These findings support the role of anatomical disease extent in preoperative counselling and individualised surgical planning.